Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population

被引:5
|
作者
Mishra, A. [1 ]
Agrawal, V [2 ]
Krishnani, N. [2 ]
Mishra, S. K. [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow 226014, Uttar Pradesh, India
关键词
DTC; oncogene; rearranged during transfection protein; ONCOGENE ACTIVATION; PROTEIN EXPRESSION; GENE REARRANGEMENTS; RET; TUMORS; CHILDREN; LESIONS; SEARCH; CANCER;
D O I
10.4103/0022-3859.57390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The prevalence of Rearranged during Transfection/ Papillary Thyroid Carcinoma (RET/PTC) rearrangement in papillary thyroid carcinoma (PTC) varies in different geographic regions and its prognostic significance remains unclear. Aim: The aim of this study was to recognize the prevalence of RET/PTC expression in PTC from the endemically iodine-deficient region in Northern India and to correlate the expression with the clinicopathologic prognostic factors. Settings and Design: Retrospective. Archival tissue used. Materials and Methods: Immunohistochemistry was performed to look for activated RET protein expression in 50 cases of PTC. No patient had any history of prior irradiation. Statistical Analysis Used: Chi-square method, Student t test, and binary regression method. A P value of <.05 was considered significant for all the tests. Results: The prevalence of RET expression was 44%. Twenty-six (52%) cases showed RET immunoreactivity in histiocytes. Immunoreactivity was the highest in the classic variant of PTC (47.5%), followed by tumors with poorly differentiated areas (25%) and follicular variant (16.7%). RET expression was more prevalent in young patients (45.5 vs. 35.3%), females (43.3 vs. 40.0%), small tumors (33.3 vs. 26.7%), multicentric tumors (36.8 vs. 33.3%), tumors with extrathyroidal invasion (38.9 vs. 32.4%), and regional lymphadenopathy (55.2 vs. 22.2%), while it was less in cases with distant metastases (20 vs. 43.9%). There was no significant correlation of immunoreactivity with any prognostic factor. However, when the cases having immunoreactivity within histiocytes (n = 26) and histiocytes + tumor tissue (n = 28) were considered, then the expression was significantly more in cases with lymphadenopathy (P values =.009, in both instances). However, the exact clinical significance of RET/PTC positive histiocytes remained unexplained. Conclusions: Prevalence of RET/PTC in our study was consistent with the reported prevalence from other geographic areas. There was no significant correlation with the clinicopathologic factors. However, uniform techniques of detection and large international collaborative studies could clear the uncertainties regarding the prognostic importance of RET/PTC.
引用
下载
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [1] RET/PTC oncogene expression in papillary thyroid carcinoma and its correlation with clinicopathologic findings
    Arpaci, Dilek
    Uzum, Ayse Kubat
    Kapran, Yersu
    Ozbey, Nese Colak
    ENDOCRINOLOGIST, 2008, 18 (05): : 233 - +
  • [2] RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation
    Shin, E
    Chung, WY
    Yang, WI
    Park, CS
    Hong, SW
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (01) : 98 - 104
  • [3] The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors
    Erdogan, M.
    Berdeli, A.
    Karadeniz, M.
    Ertan, Y.
    Cetinkalp, S.
    Saygili, F.
    Tuncyurek, M.
    Yilmaz, C.
    Tuzun, M.
    Kabalak, T.
    Uluer, H.
    Ozgen, A. G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (04) : 225 - 230
  • [4] Expression of wild type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
    Mayr, B
    Pötter, E
    Goretzki, P
    Rüschoff, J
    Dietmaier, W
    Hoang-Vu, C
    Dralle, H
    Brabant, G
    LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) : 54 - 59
  • [5] Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
    B. Mayr
    E. Pötter
    P. Goretzki
    J. Rüschoff
    W. Dietmaier
    C. Hoang-Vu
    H. Dralle
    G. Brabant
    Langenbeck's Archives of Surgery, 1999, 384 : 54 - 59
  • [6] RET EXPRESSION AND ITS CORRELATION WITH CLINICOPATHOLOGIC DATA IN PAPILLARY THYROID CARCINOMA
    Punda, Ante
    Bedekovic, Vladimir
    Baric, Ana
    Kontic, Mirko
    Colovic, Zavisa
    Rogosic, Lucija Vanjaka
    Punda, Hrvoje
    Kunac, Nenad
    Grandic, Leo
    Pisac, Valdi Pesutic
    ACTA CLINICA CROATICA, 2018, 57 (04) : 646 - 652
  • [7] RET expression and its correlation with clinicopathologic data in papillary thyroid carcinoma
    Punda, A.
    Eterovic, D.
    Markovic, V.
    Kunac, N.
    Bedekovic, V.
    Titilic, M.
    Kontic, M.
    Grandic, L.
    Pisac, V. Pesutic
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S413 - S413
  • [8] Papillary Thyroid Carcinoma and RET/PTC Oncogenes
    Erdogan, Mehmet
    Karadeniz, Muammer
    Ozgen, Ahmet Gokhan
    Berdeli, Afig
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2007, 11 (04) : 114 - 118
  • [9] Assessment of ret/PTC-l expression in papillary thyroid carcinoma
    Sheils, O
    Uhlmann, V
    Lüttich, K
    O'Donovan, M
    Bermingham, N
    Howell, D
    Picton, S
    Sweeney, E
    O'Leary, JJ
    JOURNAL OF PATHOLOGY, 2000, 190 : 7A - 7A
  • [10] Prevalence, quantitation, and biological significance of RET/PTC Rearrangements in papillary thyroid carcinoma
    Zhu, Z
    Caudill, CM
    Nikiforova, MN
    Gandhi, M
    LABORATORY INVESTIGATION, 2003, 83 (01) : 111A - 112A